Clear all

Refine your search

Content type
Firm name

740 results found


Cozen O'Connor | USA | 22 Oct 2020

Google Sued over Antitrust Allegations | Preview of 2020 AG Races | Delay of Generic Humira Challenged

Jerry Kilgore, a Member of Cozen O’Connor’s State Attorneys General Practice and former Virginia AG and Secretary…

Pearce IP | Australia | 18 Oct 2020

Pearce IP BioBlast: w/e 16 October 2020

09 Oct 20, CN: Innovent and Eli Lilly jointly announced China's NMPA has granted marketing approval for Halpryza® (biosimilar rituximab). Halpryza®…

Greenberg Traurig LLP | Global | 9 Oct 2020

GT Newsletter | Competition Currents | October 2020

On Sept. 4, 2020, the FTC approved a final order settling its complaint that AbbVie’s $63 billion acquisition of Allergan would violate federal…

Reed Smith LLP | USA | 8 Oct 2020

Disgorgement debunked: Third Circuit sets precedent rejecting courts’ authority to award monetary relief under Section 13(b) of the FTC Act

On September 30, 2020, the United States Court of Appeals for the Third Circuit reversed a historic district court award ordering disgorgement of…

Buckley LLP | USA | 2 Oct 2020

3rd Circuit: Section 13(b) of the FTC Act does not give the agency restitution power

On September 30, the U.S. Court of Appeals for the Third Circuit reversed a district court’s order of $448 million in disgorgement, concluding that…

Venable LLP | USA | 1 Oct 2020

Disgorgement Denied: Third Circuit Hands FTC a Tough Pill to Swallow Over Section 13(b) Authority

Yesterday, the Third Circuit issued an opinion in Federal Trade Commission v. AbbVie, Inc., joining the Seventh Circuit in holding that the FTC is…

K&L Gates LLP | Global | 30 Sep 2020

Deep fakes, inventorship and ethics - WIPO revised issues paper on Artificial Intelligence

One thing is clear about artificial intelligence (AI) and Intellectual Property (IP) at the moment: there are more questions than answers. Who should…

Carpenter Wellington PLLC | China | 28 Sep 2020

China Biotech M&A Deals Nearly Double by Q2 of 2020

While the rest of the world has felt the negative effects of COVID-19, China biotechnology M&A transactions have nearly doubled this year. The main…

CMS Legal | European Union, United Kingdom | 22 Sep 2020

Who dares wins: CMS European M&A Outlook 2020

Our survey provides key insights into how both corporate and private equity firms are adapting their M&A strategies to the current situation in…

Garrigues | Global | 15 Sep 2020

COVID-19 and the compulsory licensing of patents

In the context of the COVID-19 pandemic, countries may review their internal legislation on compulsory licensing of patents for medical products so…
Previous page 1 2 3 ...